Cellular senescence is a programmed state of cell cycle arrest that involves a complex immunogenic secretome, eliciting immune surveillance and senescent cell clearance. Recent work has shown that a subpopulation of pancreatic β-cells becomes senescent in the context of diabetes; however, it is not known whether these cells are normally subject to immune surveillance. In this opinion article, we advance the hypothesis that immune surveillance of β-cells undergoing a senescence stress response normally limits their accumulation during aging and that the breakdown of these mechanisms is a driver of senescent β-cell accumulation in diabetes. Elucidation and therapeutic activation of immune surveillance mechanisms in the pancreas holds promise for the improvement of approaches to target stressed senescent β-cells in the treatment of diabetes.
Click here to view the paper.
What's New


Dr. Payam Peymani Joins the DREAM Theme!


New iCARE research highlights kidney health in youth with type 2 diabetes


Canadian Lipid and Vascular Summit 2026


15th Annual DREAM Symposium and DREAM Trainee Day


Now Recruiting Participants for a Research Study!



